Mei Wei MD

Dr. Mei Wei is a breast medical oncologist at the University of Utah whose clinical practice focuses on the comprehensive and compassionate care of patients with all subtypes of breast cancer, spanning early-stage to metastatic disease. Her primary clinical and research interests center on the management of HER2-positive breast cancer and the advancement of personalized treatment strategies across all breast cancer subtypes. Dr. Wei is deeply committed to patient-centered care and believes that individuals have the fundamental right to determine the extent of medical intervention they wish to pursue, free from judgment. She strives to align evidence-based treatment guidelines with each patient’s unique goals, values, and preferences, ensuring that care delivery is individualized rather than prescriptive.

An advocate for the integration of telemedicine into oncology practice, Dr. Wei recognizes its potential to enhance access to care, reduce logistical and financial barriers, and promote continuity of care while minimizing disruption to patients’ daily lives. Her research portfolio includes prospective clinical trials and retrospective outcomes studies in breast cancer. Dr. Wei is particularly interested in utilizing large clinical databases and real-world evidence to address critical questions that may not be answered through traditional clinical trial frameworks, with the overarching aim of improving patient outcomes and advancing the field of breast oncology.